Starpharma (ASX:SPL) share price sinks 5% despite new board member

The company's shares are reversing yesterday's gains.

| More on:
share price plummeting down

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Starpharma Holdings Limited (ASX: SPL) share price is deep in negative territory during early afternoon trade. This comes despite the healthcare company announcing an inclusion to its board.

At the time of writing, Starpharma shares are down 5.15% to $1.29.

Starpharma strengthens its board

A possible catalyst to the fall of Starpharma shares is the strong gains made the day before. It appears profit takers have swopped in after the company's share price ended yesterday with a 7.94% increase.

In today's statement, Starpharma announced that experienced finance executive, Lynda Cheng will join the board. The new addition will see Ms Cheng appointed as non-executive director from the beginning of next month.

Starpharma noted that Ms Cheng brings a wealth of knowledge, having served more than 25 years as a finance executive. This includes 15 years at recycling and cardboard box manufacturing giant, Visy Industries/Pratt Holdings, and 10 years in investment banking.

Currently, Ms Cheng is the director of Corporate Development and Mergers & Acquisitions at Visy Industries/Pratt Holdings. She has held various roles throughout her career there, with her most notable position as chief financial officer.

Furthermore, Ms Cheng is also a non-executive director at Export Finance Australia and a member of Wesley College Council.

Prior to this, Ms Cheng was a member of the Australian Government's International Development Policy Expert Panel, as well as deputy chair and chair of the Finance, Audit and Risk Committee of South East Water.

Starpharma chair, Rob Thomas commented on Ms Cheng's new title, saying:

We are delighted to welcome Lynda at an exciting time for the Company. Lynda brings broad commercial and international corporate expertise as well as an extensive professional network. She has deep experience in financial services, manufacturing, innovation, technology and new market entry.

The appointment of Ms Cheng will add further value to the Starpharma board. As such, Ms Cheng will join the Audit and Risk Committee upon her appointment.

Ms Cheng studied at the University of Melbourne and holds a Bachelor of Law (Honours) and Commerce degree majoring in actuarial studies and economics.

Starpharma share price review

Since hitting an all-time high of $2.52 in February 2021, Starpharma shares have moved on a downwards trajectory. Over the past 12 months, the company's share price is up more than 10%, but down almost 20% year-to-date.

Starpharma commands a market capitalisation of roughly $517.7 million, with 406 million shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Starpharma Holdings Limited. The Motley Fool Australia has recommended Starpharma Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »